Cytochrome P450 and Transporters
Showing 1 - 25 of 1,206
Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)
Recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- Dasatinib Pill
- Ketoconazole Pill
-
Monterrey, Nuevo Leon, MexicoHospital Universitario Dr. José Eleuterio González
Nov 25, 2022
Antipsychotic Induced Weight Gain, Non-alcoholic Steatohepatitis (NASH) Trial in Miami (Miricorilant, Fluvoxamine)
Recruiting
- Antipsychotic Induced Weight Gain
- Non-alcoholic Steatohepatitis (NASH)
-
Miami, FloridaSite 01
Feb 3, 2023
Atopic Dermatitis Trial (Caffeine, Metoprolol, Midazolam)
Not yet recruiting
- Atopic Dermatitis
- Caffeine
- +6 more
- (no location specified)
May 26, 2023
Macrophage Function
Enrolling by invitation
- Polymorphism
- Lung Inflammation
-
Research Triangle Park, North CarolinaNIEHS, Research Triangle Park
Jul 6, 2022
Parkinson Disease Trial in Madison (Tavapadon, Carbamazepine)
Active, not recruiting
- Parkinson Disease
-
Madison, WisconsinMadison, Wisconsin
Jan 13, 2023
HIV Trial in Baltimore (VH4524184, Midazolam, Placebo)
Recruiting
- HIV Infections
- VH4524184
- +2 more
-
Baltimore, MarylandGSK Investigational Site
Jan 11, 2023
Drug-Interactions Trial in Baltimore (Inje cocktail, THC Cannabis extract, THC/CBD Cannabis Extract)
Active, not recruiting
- Drug-Interactions
- Inje cocktail
- +2 more
-
Baltimore, MarylandJohns Hopkins University
Mar 21, 2022
Atopic Dermatitis Trial in Bulgaria, United States (Nemolizumab, CYP 450 Substrates)
Recruiting
- Atopic Dermatitis
- Nemolizumab
- CYP 450 Substrates
-
North Hollywood, California
- +6 more
Nov 29, 2022
Healthy Trial in Geneva (Dextromethorphan 5 MG, Paroxetine 10Mg Tablet, Paroxetine 20Mg Tablet)
Completed
- Healthy
- Dextromethorphan 5 MG
- +2 more
-
Geneva, SwitzerlandHUG
Jan 3, 2022
Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)
Completed
- Ulcerative Colitis (UC)
- Crohn's Disease
- Risankizumab
- Cytochrome P450 (CYP) Substrates
-
Coronado, California
- +5 more
Oct 20, 2022
Drug-drug Interactions Trial in DeLand (napabucasin, cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate)
Completed
- Drug-drug Interactions
- napabucasin
- cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate
-
DeLand, FloridaAccel Research Sites
Apr 4, 2022
Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)
Not yet recruiting
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
- Vesatolimod
- +3 more
- (no location specified)
Jul 11, 2022
Healthy Trial in Salt Lake City (BMS-986165, Fluvoxamine)
Completed
- Healthy
-
Salt Lake City, UtahICON Plc (PRA Health Sciences)
Nov 9, 2021
Crohn Disease, Ulcerative Colitis Trial in Worldwide (Ustekinumab IV Infusion, Ustekinumab SC Injection, Midazolam 2 mg)
Suspended
- Crohn Disease
- Ulcerative Colitis
- Ustekinumab IV Infusion
- +7 more
-
Cypress, California
- +15 more
Jul 21, 2022
Drug Intolerance, Cytochrome P450 CYP2D6 Enzyme Deficiency, Drug Effect Trial in Geneva (Pupillometry)
Terminated
- Drug Intolerance
- +2 more
- Pupillometry
-
Geneva, SwitzerlandGeneva University Hospitals, Geneva, Switzerland
Nov 24, 2022
Healthy Volunteer Trial in London (CC-99677, Methotrexate, Sulfasalazine)
Completed
- Healthy Volunteer
- CC-99677
- +8 more
-
London, United KingdomRichmond Pharmacology Limited
Aug 17, 2021
Healthy Volunteers Trial in Berlin (Zoliflodacin Patheon)
Recruiting
- Healthy Volunteers
- Zoliflodacin Patheon
-
Berlin, GermanyParexel Early Phase Clinical Unit
Nov 22, 2022
Healthy Trial in San Antonio (TD-1211, TD-1211+ itraconazole)
Completed
- Healthy
- TD-1211
- TD-1211+ itraconazole
-
San Antonio, TexasIcon Development Services
Jan 15, 2021
Cytochrome P450 Abnormalities in Patients With Delirium.
Completed
- Delirium, Cytochrome P-450 Enzyme System
- Cytochrome P450 test
-
Park Ridge, IllinoisDavid Ronin
Jul 14, 2020
Based on CYP2C19 Genotype in Ischemic Stroke
Active, not recruiting
- Acute Ischemic Stroke
- General principles of care and judgement of researcher
-
Yongin-si, Gyeonggi-do, Korea, Republic of
- +36 more
Oct 23, 2022